Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease

NCT04335721 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT04335721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04335721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease
Lead sponsor
University of Illinois at Chicago
Phase
Phase 1/2
Overall status
Terminated
Start date
March 16, 2021
Completion date
October 7, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease, sickle cell nephropathy